Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
(NASDAQ: XGN) Delayed: 4.36 -0.06 (1.36%)
Previous Close $4.42    52 Week High $0.46 
Open $4.31    52 Week Low $0.46 
Day High $4.62    P/E N/A 
Day Low $4.31    EPS $0.00 
Volume 104,156       

(NASDAQ: XGN) Delayed: 4.36 -0.06 (1.36%)
Previous Close $4.42    52 Week High $0.46 
Open $4.31    52 Week Low $0.46 
Day High $4.62    P/E N/A 
Day Low $4.31    EPS $0.00 
Volume 104,156